Sacubitril/valsartan bests valsartan alone in analysis of patients in PARAGON-HF trial
WASHINGTON -- Combination sacubitril and valsartan (Entresto) was associated with significantly fewer renal outcomes than valsartan alone among patients with heart failure (HF) and preserved ejection fraction (HFrEF), a researcher said here.